Duke Health Provider
Jeffrey A. Dvergsten, MD
Pediatric Rheumatologist
Duke Health Provider
Accepting New Patients
Call for an Appointment
Where I See Patients
Duke Children's Health Center Rheumatology Clinic - Durham, NC
Duke Children's Rheumatology Creekstone - Durham, NC
Board Certified
American Board of Pediatrics, General Pediatrics
American Board of Pediatrics, Pediatric Rheumatology
Call for an Appointment
Schedule Online
My Locations
Fax:
919-684-6616
Fax:
919-576-8806
About Me
Current Appointments and Affiliations
- Associate Professor of Pediatrics, Pediatrics, Rheumatology 2021
Languages I Speak
English
Call for an Appointment
Ratings and Reviews
The ratings and reviews are based on patient responses to the overall provider rating question from the survey. The question reads: “Using any number from 0 to 10, where 0 is the worst provider possible and 10 is the best provider possible, what number would you use to rate this provider?” Responses are converted to a 5-point rating system and applied consistently to all providers. Learn more about our survey process. Patients who see some types of providers receive a different version of the patient satisfaction survey. Those results are not available on DukeHealth.org.
Training and Education
Board Certification
American Board of Pediatrics, General Pediatrics
American Board of Pediatrics, Pediatric Rheumatology
Fellowship
Pediatric Intensive Care, University of Minnesota Medical Center, 2002
Pediatric Rheumatology, Children's Hospital of Pittsburgh (Pennsylvania), 2007-2010
Residency
Pediatrics, University of Minnesota Medical Center, 1999-2002
Education
MD, University of Minnesota Medical School, 1993
Clinical Focus and Research
Publications and Grants
Grants6
Academic Articles22
Book Sections3
Conference Papers4
- Pediatrics Juvenile Myositis program support awarded by Cure JM Foundation 2019 - 2025
- Covert, Lauren T., Joseph A. Prinz, Devjanee Swain-Lenz, Jeffrey Dvergsten, and George A. Truskey. “Genetic changes from type I interferons and JAK inhibitors: clues to drivers of juvenile dermatomyositis.” Rheumatology (Oxford) 63, no. SI2 (September 1, 2024): SI240–48. https://doi.org/10.1093/rheumatology/keae082.
- Covert, Lauren T., Hailee Patel, Alaa Osman, Lavonia Duncan, Jeffrey Dvergsten, and George A. Truskey. “Effect of type I interferon on engineered pediatric skeletal muscle: a promising model for juvenile dermatomyositis.” Rheumatology (Oxford, England) 63, no. 1 (January 2024): 209–17. https://doi.org/10.1093/rheumatology/kead186.
- Wahezi, Dawn M., Dominique Jerome, Evin Rothschild, Belina Yi, Jeffrey Dvergsten, Stacey Tarvin, Susan Kim, Tamar Rubinstein, and CARRA JDM workgroup. “The impact of the COVID-19 pandemic on patients with juvenile idiopathic inflammatory myopathies.” Pediatr Rheumatol Online J 21, no. 1 (September 12, 2023): 100. https://doi.org/10.1186/s12969-023-00873-0.
- Dvergsten, J. A., and A. M. Reed. “Juvenile Dermatomyositis.” In Nelson Textbook of Pediatrics: Volume 1-2, 1500-1506.e1, 2024. https://doi.org/10.1016/B978-0-323-88305-4.00200-5.
- Dvergsten, J. A., and C. E. Rabinovich. “Treatment of Rheumatic Diseases.” In Nelson Textbook of Pediatrics: Volume 1-2, 1463-1470.e1, 2024. https://doi.org/10.1016/B978-0-323-88305-4.00195-4.
- Dvergsten, Jeffrey, and Ann Reed. “Management Considerations: Juvenile Dermatomyositis.” In Managing Myositis A Practical Guide, edited by Rohit Aggarwal and Chester Oddis. Springer, 2019.
- Crowson, Cynthia S., Molly S. Hein, Richard S. Pendegraft, Michael A. Strausbauch, Timothy B. Niewold, Floranne C. Ernste, Jeffrey Dvergsten, et al. “Interferon Chemokine Score and Other Cytokine Measures Track With Changes in Disease Activity in Patients With Juvenile and Adult Dermatomyositis.” In ACR Open Rheumatol, 1:83–89, 2019. https://doi.org/10.1002/acr2.1011.
- Ferguson, Ian D., Patricia Griffin, Hiroshi Yano, Joshua J. Michel, Jeffrey A. Dvergsten, Sarah L. Gaffen, Margalit E. Rosenkranz, Daniel A. Kietz, and Abbe N. Vallejo. “Interaction Between Senescent T Cells and Fibrocyte-like Cells through CD31, TNF alpha, and IL-17 Create a Tissue Destructive Environment in the Synovium in Juvenile Idiopathic Arthritis.” In ARTHRITIS & RHEUMATOLOGY, Vol. 67. WILEY-BLACKWELL, 2015.
- Kalampokis, Ioannis, Jeffrey A. Dvergsten, and Thomas Tedder. “The Interleukin-10 (IL-10) Producing Regulatory B Cell ("B10 cell") Compartment Expands with Disease Activity in Juvenile Dermatomyositis (JDM) and Pediatric-Onset Systemic Lupus Erythematosus (pSLE).” In ARTHRITIS AND RHEUMATISM, 64:S138–S138. WILEY-BLACKWELL, 2012.
Insurance Accepted
Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below.
-
Aetna
- Aetna Choice POS, Aetna Choice POS II
- Aetna Elect Choice HMO, Aetna Open Access Elect Choice
- Aetna Health Network Only, Aetna Health Network Option
- Aetna HMO
- Aetna Limited Benefit Insurance PPO
- Aetna Managed Choice POS
- Aetna Medicare Assure Plan (HMO D-SNP)
- Aetna Medicare Eagle Plan (PPO)
- Aetna Medicare Essential Plan (PPO)
- Aetna Medicare Value Plan (HMO)
- Aetna Open Access HMO, Open Access Aetna Select, Aetna Open Access Managed Choice
- Aetna Open Choice PPO
- Aetna PCP Coordinated POS Plan
- Aetna Quality Point of Service (QPOS)
- Aetna Select HMO
- Aetna Traditional Choice
- Aetna Voluntary Indemnity Group Plan
- Aetna Whole Health – Duke WakeMed WKCC
- Aetna/CVS Health
-
Ambetter
- Ambetter of North Carolina
-
Blue Cross Blue Shield of NC
- Blue Advantage
- Blue Medicare (HMO, PPO)*
- Blue Options (123, PPO, HSA)
- Blue Select
- NC State Employees Health Plan
-
*Duke HomeCare and Hospice does not participate in the plan.
-
Cigna
- Cigna Behavioral Health (*Limited eligibility)
- Cigna Choice Plus
- Cigna Connect Individual Family Plan
- Cigna Open Access
- Cigna Open Access Plus
-
*Please call Cigna Behavioral Heath to see if the provider is participating in your plan.
-
Duke Group Plans
- Duke Basic
- Duke Select
-
Experience Health
- Experience Health Medicare Advantage (HMO) Plan
- Gateway Health Alliance
- Healthgram
-
Humana
- Humana Choice (PPO)
- Humana Choice - Medicare Advantage (PPO)
- Humana ChoiceCare - Medicare Advantage (PPO)
- Humana Gold Choice - Medicare Advantage (PFFS)
- Humana Gold Plus - Medicare Advantage (HMO)
- Humana Medicare Advantage Group Plan - NC State Retirees
- MedCost
-
Medicare
- First Medicare Direct
- Medicare Part A
- Medicare Part B
-
NC Medicaid
- AmeriHealth Caritas North Carolina
- Carolina Complete Health
- Healthy Blue
- NC Medicaid Direct
- WellCare of North Carolina
-
TRICARE
- TRICARE Prime
- TRICARE Prime Remote
- TRICARE Select
-
United Healthcare
- AARP Medicare Advantage Plan 2 (HMO-POS)
- AARP Medicare Complete (HMO, PPO)*
- AARP Medicare Complete Essential (HMO)*
- All Savers Alternate Funding
- All Savers Fully Insured
- United Healthcare (HMO, PPO, POS)**
- United Healthcare Charter/Charter Balance/Charter Plus
- United Healthcare Choice/Choice Plus
- United Healthcare Core/Core Essential
- United Healthcare Navigate/Navigate Plus/Navigate Balanced
- United Healthcare Option PPO
- United Healthcare Passport Connect Choice/Choice Plus
- United Healthcare Passport Connect Options PPO
- United Healthcare Select/Select Plus
- United Healthcare Shared Services - Harvard Pilgrim/UHC Options PPO Network
- United Medical Resources (UMR)
-
*Duke HomeCare and Hospice and mental health providers do not participate with the plan.
-
**Duke Health does not participate in UHC plans on the Health Insurance Marketplace.
Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.
External Relationships
This faculty member (or a member of their immediate family) has reported outside activities with the companies or institutions listed below. This information has been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts of interest.
- Rare Disease Research